Kaitlyn Moore, NP
Adult Health · Hahira, GANPI 1811368939
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Amgen at 54.6% of the total. Reporting peaked in 2023 at $5,004 and has fallen 95.9% since, to $203 in 2025. Among adult health clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 175 payments — averaging $44.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- Novartis$525
- Eisai Inc.$319
- AstraZeneca$305
- GSK$281
- Pfizer$265
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$3,37543%
- Travel & lodging$7369%
- Food & beverage$3,56846%
- Education$901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $4,240 |
| Novartis | 33 | $525 |
| Eisai Inc. | 6 | $319 |
| AstraZeneca(2 entities) | 16 | $305 |
| GSK | 4 | $281 |
| Pfizer | 14 | $265 |
| Daiichi Sankyo Inc. | 5 | $202 |
| E.r. Squibb & Sons, L.L.C. | 8 | $191 |
| Incyte Corporation | 6 | $184 |
| Gilead | 8 | $161 |
| Merck | 6 | $139 |
| Genentech USA, Inc. | 5 | $109 |
| Bristol Myers Squibb | 5 | $104 |
| AbbVie | 4 | $81 |
| Bayer | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| Sobi, Inc | 3 | $57 |
| Astellas Pharma US Inc | 3 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Lilly USA, LLC | 2 | $40 |
| Rigel Pharmaceuticals, Inc. | 2 | $39 |
| Sanofi | 2 | $38 |
| Beone Medicines USA, Inc. | 1 | $34 |
| Johnson & Johnson | 2 | $33 |
| Myriad Genetic Laboratories, Inc. | 2 | $28 |
| Mindray DS USA, Inc. | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
| Pharmaessentia USA Corporation | 1 | $20 |
| Seagen Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $14 |
| Servier Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,769 in reported general payments places this provider in the 90th percentile of 577 adult health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $9,989 |
| Potassium Chloride | 47 | $891 |
| ValacyclovirValacyclovir Hcl | 11 | $463 |
| Letrozole | 17 | $439 |
| Tamoxifen Citrate | 13 | $343 |
| Megestrol Acetate | 24 | $336 |
| Warfarin Sodium | 68 | $303 |
| Hydroxyurea | 12 | $265 |
| Ciprofloxacin Hcl | 11 | $128 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 12 | $84 |
| Gabapentin | 13 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $265 | $9,98915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 577 adult health providers in Georgia.
Other adult health in Hahira
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
- Kristine AdamsMarietta$21K
- Jenina LagascaAtlanta$17K
- Jennifer SheldonMacon$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.